Table 1. 16-State Study indicator workgroups
| Workgroup |
| A1. |
Penetration/Utilization Rates |
| A2,Q1, Q4, O1. |
Adult Consumer Survey |
| |
Children and Family Consumer Survey |
| Q3. |
Consumers are Contacted Within 7 Days of Discharge |
| Q11 |
Readmission w/in 30 days |
| S3: |
Costs |
| Q2: |
Consumers linked to primary health care |
| O3: |
Employment |
| O9: |
Mortality |
| O12: |
Living Situation |
| O13(a): |
Criminal Justice Data-Self-Report Data |
| O13(b): |
Criminal Justice Data-Linking to Criminal Justice |
| Q5. |
Percent of Adults with SMI Receiving ACT |
| Q6: |
Percent of Adults with SMI Receiving Supported Employment |
| Q7: |
Percent of Adults with SMI Receiving Supported Housing |
| O4: |
Level of Functioning |
| O5: |
Symptoms |
| O14: |
Recovery: when available |
| O11: |
Reduced Substance Abuse |
| S1: |
Stakeholder Involvement in Policy and Planning |
| Q8: |
Percentage of Adults with Schizophrenia Receiving New Generation Anti-psychotic
(atypical) medications |
| Q12: |
Seclusion Rate |
| Q13: |
Restraint Rates |
| Q14: |
Medication Errors |
| O6: |
Injuries |
| O7: |
Elopements |
